Literature DB >> 23026527

S100A4 siRNA inhibits human pancreatic cancer cell invasion in vitro.

Na Li1, Mao Min Song, Xiao Hua Chen, Li Hui Liu, Feng Sheng Li.   

Abstract

OBJECTIVE: Pancreatic cancer is one of the most deadly cancers, which is characterized by its high metastatic potential. S100A4 is a major prometastatic protein involved in tumor invasion and metastasis which precise role in pancreatic cancer has not been fully investigated. We knocked down the S100A4 gene in the Bxpc-3 pancreatic cancer cell line via RNA interference to study the changes in cell behavior.
METHODS: Real-time polymerase chain reaction and western blotting were used to detect mRNA and protein expression levels of S100A4, matrix metalloproteinase (MMP)-2, E-cadherin and thrombospondin (TSP)-1. Transwell chambers were used to detect the migration and invasion abilities; a cell adhesion assay was used to detect adhesion ability; colony forming efficiency was used to detect cell proliferation; flow cytometry was used to detect apoptosis.
RESULTS: S100A4 mRNA expression was reduced to 17% after transfection with S100A4-siRNA, and protein expression had a similar trend. mRNA and protein expression of MMP-2 was reduced and that of E-cadherin and TSP-1 was elevated, indicating that S100A4 affects their expression. S100A4-silenced cells exhibited a marked decrease in migration and invasiveness and increased adhesion, whereas overall proliferation and apoptosis were not overtly altered.
CONCLUSION: S100A4 and its downstream factors play important roles in pancreatic cancer invasion, and silencing A100A4 can significantly contain the invasiveness of pancreatic cancer.
Copyright © 2012 The Editorial Board of Biomedical and Environmental Sciences. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23026527     DOI: 10.3967/0895-3988.2012.04.012

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  9 in total

1.  Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer.

Authors:  Li Xiao; Ulrike Erb; Kun Zhao; Thilo Hackert; Margot Zöller
Journal:  Oncoimmunology       Date:  2017-04-20       Impact factor: 8.110

2.  Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target.

Authors:  Kati Rasanen; Sira Sriswasdi; Alexander Valiga; Hsin-Yao Tang; Gao Zhang; Michela Perego; Rajasekharan Somasundaram; Ling Li; Kaye Speicher; Andres J Klein-Szanto; Devraj Basu; Anil K Rustgi; David W Speicher; Meenhard Herlyn
Journal:  Mol Cell Proteomics       Date:  2013-09-13       Impact factor: 5.911

Review 3.  Joining S100 proteins and migration: for better or for worse, in sickness and in health.

Authors:  Stephane R Gross; Connie Goh Then Sin; Roger Barraclough; Philip S Rudland
Journal:  Cell Mol Life Sci       Date:  2013-06-30       Impact factor: 9.261

4.  S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase.

Authors:  Pulin Che; Youfeng Yang; Xiaosi Han; Meng Hu; Jeffery C Sellers; Angelina I Londono-Joshi; Guo-Qiang Cai; Donald J Buchsbaum; John D Christein; Qinjiu Tang; Dongquan Chen; Qianjun Li; William E Grizzle; Yin Ying Lu; Qiang Ding
Journal:  Sci Rep       Date:  2015-02-13       Impact factor: 4.379

5.  Knockdown of S100A11 expression suppresses ovarian cancer cell growth and invasion.

Authors:  Youqing Liu; Xiaobing Han; Baoan Gao
Journal:  Exp Ther Med       Date:  2015-02-03       Impact factor: 2.447

Review 6.  Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis.

Authors:  Shanshan Huang; Jiawei Zheng; Yufang Huang; Li Song; Yin Yin; Danzhen Ou; Shangxiang He; Xiong Chen; Xuenong Ouyang
Journal:  Dis Markers       Date:  2016-01-19       Impact factor: 3.434

7.  Silencing of S100A4, a metastasis-associated protein, in endothelial cells inhibits tumor angiogenesis and growth.

Authors:  Takahiro Ochiya; Keizo Takenaga; Hideya Endo
Journal:  Angiogenesis       Date:  2013-08-09       Impact factor: 9.596

8.  Small interfering RNA targeting S100A4 sensitizes non-small-cell lung cancer cells (A549) to radiation treatment.

Authors:  Ruixue Qi; Tiankui Qiao; Xibing Zhuang
Journal:  Onco Targets Ther       Date:  2016-06-23       Impact factor: 4.147

Review 9.  Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy.

Authors:  Sepideh Mirzaei; Mohammad Hossein Gholami; Hui Li Ang; Farid Hashemi; Ali Zarrabi; Amirhossein Zabolian; Kiavash Hushmandi; Masoud Delfi; Haroon Khan; Milad Ashrafizadeh; Gautam Sethi; Alan Prem Kumar
Journal:  Cells       Date:  2021-11-29       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.